A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Recruiting

Phase 1

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Sponsor:

Jiangsu Simcere Pharmaceutical Co., Ltd.

Code:

NCT05569057

Conditions

Advanced Solid Tumor

Cutaneous T-cell Lymphoma (CTCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SIM1811-03

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information